Number | Date | Country | Kind |
---|---|---|---|
PQ5701 | Feb 2000 | AU |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/JP01/00997 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO01/60813 | 8/23/2001 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
5707994 | Ikeda et al. | Jan 1998 | A |
6066651 | Hoekstra | May 2000 | A |
6069254 | Costanzo et al. | May 2000 | A |
6380215 | Ohkubo et al. | Apr 2002 | B1 |
6384028 | Ohkubo et al. | May 2002 | B1 |
6538007 | Ohkubo et al. | Mar 2003 | B1 |
Number | Date | Country |
---|---|---|
95 08536 | Mar 1995 | WO |
95 25091 | Sep 1995 | WO |
96 29309 | Sep 1996 | WO |
97 33869 | Sep 1997 | WO |
97 41102 | Nov 1997 | WO |
99 21832 | May 1999 | WO |
00 21932 | Apr 2000 | WO |
Entry |
---|
Hoekstra et al. “Design and evaluation of nonpeptide fibrinogen . . . ” CA 123:56546 (1995).* |
Hoekstra et al.: “Potent, orally active GPllb/llla antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308” Journal of Medicinal Chemistry, American Chemical Society, vol. 42, No. 25, pp. 5254-5265 1999. |
W. Hoekstra et al.: “Design and evaluation of nonpeptide fibrinogen gamma-chain based GPllB/lllA antagonists”, Journal of Medicinal Chemistry, American Chemical Society, vol. 38, No. 10, pp. 1582-1592 1995. |